Abstract
Background
The complex effects of Long-COVID, a syndrome marked by enduring symptoms after COVID-19 infection, with an emphasis on patients’ differing degrees of fibro fatigue (FF). Electrolyte disturbances may affect the severity of FF and may be used as a predictive tool for severe FF in Long-COVID patients.
Objective
The aim is to use the electrolyte levels for prediction of the Long-COVID patients with high FF levels.
Methods
The electrolyte levels, calcium, and magnesium, as well as albumin and C-reactive protein levels were measured in 120 Long-COVID patients and 60 controls. FF scale was used for scoring the fatigue severity in all subjects. Patients were divided into high-FF (FF score>25) and moderate-FF group (FF score<25).
Results
FF is the major effector on the serum biomarker levels. High-FF group had older people, longer disease durations, lower SpO2, higher CRP, and higher peak temperatures than the control group. High-FF group has a significant decrease in serum total and ionized calcium compared with the controls and low-FF group. After controlling the cofounders, the major factor controlling the levels of the measured biomarkers is the FF value (Partial η2 = 0.468). The ROC-AUC analysis showed that the peak body temperature, Low-SpO2, high-CRP, and low electrolytes can predict the high-FF in a patient with Long-COVID with a moderate sensitivity and specificities (61.6–70%).
Conclusion
Long-COVID patients have an elevation in FF score. The decline in electrolytes can predict the severity of FF with moderate sensitivities and specificities.
Publisher
Public Library of Science (PLoS)
Reference58 articles.
1. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline;W Shah;BMJ,2021
2. Understanding How Post–COVID-19 Condition Affects Adults and Health Care Systems;GM Katz;JAMA Health Forum,2023
3. Long COVID: major findings, mechanisms and recommendations;HE Davis;Nature Reviews Microbiology,2023
4. Unexplained post-acute infection syndromes;J Choutka;Nature medicine,2022
5. Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications;C Calabrese;Best Practice & Research Clinical Rheumatology,2022